| Indicators | Browse All

Vyome Holdings, Inc. (HIND)

Healthcare | Biotechnology | Cambridge, United States | NasdaqCM
1.97 USD -0.04 (-1.990%) ⇩ (Oct. 13, 2026, 4 p.m. EDT)

Short-term:★★☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 5:36 a.m. EDT

The short-term outlook remains cautiously bearish due to persistent downward pressure; the stock has traded below its 50-day and 200-day moving averages, indicating a lack of immediate momentum despite a slight recent bounce. While the statistical forecast model suggests a moderate probability of a minor decline over the next month, this technical weakness is overshadowed by the company's severe fundamental deterioration. From a long-term perspective, the investment case is effectively broken: the business has suffered a catastrophic collapse in value, with the share price plunging nearly 99% over the last decade and recording four consecutive years of negative annual returns. This multi-year decline signals a structural failure in the business model rather than a temporary setback, rendering any current valuation metrics meaningless. Furthermore, the company is burning cash with negative operating cash flow and negative returns on equity, while offering no dividend income whatsoever. The combination of a shrinking pie, no income distribution, and a deteriorating balance sheet makes this a clear avoidance.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.041124
MSTL0.041370
AutoETS0.041410
AutoARIMA0.044349

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 46%
H-stat 1.74
Ljung-Box p 0.000
Jarque-Bera p 0.286
Excess Kurtosis -1.02
Attribute Value
Sector Healthcare
Debt to Equity Ratio 0.237
Revenue per Share 0.018
Market Cap 13,826,500
Trailing P/E 1.11
Website https://www.vyometx.com

Info Dump

Attribute Value
52 Week Change -0.6207547
Address1 Harvard Square
Address2 One Mifflin Place Suite 400
All Time High 138,156,000.0
All Time Low 1.75
Ask 2.44
Ask Size 2
Average Analyst Rating 1.3 - Strong Buy
Average Daily Volume10 Day 10,280
Average Daily Volume3 Month 12,965
Average Volume 12,965
Average Volume10Days 10,280
Bid 1.42
Bid Size 2
Book Value 0.862
City Cambridge
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.97
Current Ratio 4.373
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 2.09
Day Low 1.97
Debt To Equity 0.237
Display Name Vyome
Dividend Yield 0.0
Earnings Timestamp End 1,763,064,000
Earnings Timestamp Start 1,763,064,000
Ebitda -4,205,649
Ebitda Margins 0.0
Enterprise To Ebitda -1.717
Enterprise To Revenue 55.652
Enterprise Value 7,219,520
Eps Trailing Twelve Months 1.78
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 2.11084
Fifty Day Average Change -0.14084005
Fifty Day Average Change Percent -0.066722274
Fifty Two Week Change Percent -62.07547
Fifty Two Week High 6.56
Fifty Two Week High Change -4.59
Fifty Two Week High Change Percent -0.69969517
Fifty Two Week Low 1.75
Fifty Two Week Low Change 0.22000003
Fifty Two Week Low Change Percent 0.1257143
Fifty Two Week Range 1.75 - 6.56
Financial Currency USD
First Trade Date Milliseconds 1,475,760,600,000
Float Shares 3,645,845
Free Cashflow 3,641,658
Full Exchange Name NasdaqCM
Full Time Employees 9
Fullday Change -0.03999996
Fullday Change Percent -1.9900478
Fullday Price 1.97
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.52742
Gross Profits 68,420
Has Pre Post Market Data 1
Held Percent Insiders 0.52881
Held Percent Institutions 0.02178
Implied Shares Outstanding 7,018,528
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,755,216,000
Last Split Factor 1:4
Long Business Summary Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts.
Long Name Vyome Holdings, Inc.
Market us_market
Market Cap 13,826,500
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_115222623
Most Recent Quarter 1,782,777,600
Net Income To Common -11,307,741
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 13,966,870
Number Of Analyst Opinions 3
Open 2.09
Operating Cashflow -5,578,745
Operating Margins -32.00022
Payout Ratio 0.0
Phone 973 832 8147
Previous Close 2.01
Price Hint 4
Price To Book 2.285383
Price To Sales Trailing12 Months 106.58316
Profit Margins 0.0
Quick Ratio 4.312
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.33333
Region US
Regular Market Change -0.03999996
Regular Market Change Percent -1.9900478
Regular Market Day High 2.09
Regular Market Day Low 1.97
Regular Market Day Range 1.97 - 2.09
Regular Market Open 2.09
Regular Market Previous Close 2.01
Regular Market Price 1.97
Regular Market Time 1,791,921,600
Regular Market Volume 9,961
Return On Assets -0.48791
Return On Equity -9.99174
Revenue Growth -0.46
Revenue Per Share 0.018
Sand P52 Week Change 0.17502642
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 7,018,528
Shares Percent Shares Out 0.0037
Shares Short 26,227
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 19,043
Short Name Vyome Holdings, Inc.
Short Percent Of Float 0.0058
Short Ratio 1.34
Source Interval 15
State MA
Symbol HIND
Target High Price 15.0
Target Low Price 3.5
Target Mean Price 8.83333
Target Median Price 8.0
Total Cash 7,887,510
Total Cash Per Share 1.124
Total Debt 17,310
Total Revenue 129,725
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 1.78
Trailing P E 1.1067415
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 2.35404
Two Hundred Day Average Change -0.38403988
Two Hundred Day Average Change Percent -0.16314077
Type Disp Equity
Volume 9,961
Website https://www.vyometx.com
Zip 2,138